ADVERTISEMENT

 
FAN logo

Share

    


In This Section

Sign Up For FAN Updates

Home / Learn / Financial Advocacy

Financial Advocacy

The Association of Cancer Care Centers (ACCC) is committed to building the confidence of oncology financial advocates, connecting them with much-needed solutions to improve the patient experience. Through the Financial Advocacy Network’s tools and resources, ACCC empowers cancer programs and practices to proactively integrate financial health into the oncology care continuum and help patients gain access to high-quality care for a better quality of life.

For more information on this project, please contact the ACCC Provider Education department.

 

Featured Programs

Financial Advocacy Guidelines

These guidelines were created using a collaborative, consensus-based process to promote and guide the implementation of critical financial advocacy services in cancer programs and practices across the nation.

Financial Advocacy Boot Camp

Whether you are an experienced financial advocate or new to the field, the ACCC Financial Advocacy Boot Camp prepares you to help your patients and your program address the growing issue of financial toxicity.

Financial Advocacy Playbook

The ACCC Financial Advocacy Network brought together experts in financial advocacy to create this Playbook—a comprehensive tool to support onboarding and continuous learning for staff who deliver financial advocacy services.

Prior Authorization Clinic

ACCC is developing an educational program that will foster discussions on how to ease provider burden and ensure the best quality care for the patient when dealing with the utilization management technique known as prior authorization.

Financial Advocacy: Foundation of Biomarker Testing Courses

Learn the fundamentals of biomarker and diagnostic testing as it relates to financial navigation. Gain confidence in your ability to guide patients through the complex insurance process, practice clear communication strategies, and access helpful financial resources.

Financial Advocacy Toolkit

ACCC, its members, and partners have collected new and updated resources to help you develop, implement, and continue to deliver effective financial advocacy services in your cancer program or practice.

Patient Assistance & Reimbursement Guide

Access the most up-to-date anti-cancer medication assistance and reimbursement programs that are available to help alleviate the financial burden of cancer treatment. Search for applicable Oncology-Related Products and Companies and apply optional Coverage and Assistance Type filters to streamline your results.

FAN Community (ACCC Members Only)

The Financial Advocacy Network Community is a private forum for ACCC members to ask questions, share resources and experiences, and offer support for delivering financial advocacy services to your patients. You will need to login to your ACCC member account in order to access this benefit.

 

On-Demand Webinars

  • In this final webinar, hear from our experts Jordan Karwedsky, Financial Counselor, Green Bay Oncology, Wendi Waugh, BS, RT(R)(T), CMD, CRT, Administrative Director of SOMC Cancer Services & Ambulatory Infusion, Southern Ohio Medical Center, and Dr. Michael R. Gieske, Director of Lung Cancer Screening. Join us as we discuss prior authorization challenges in biomarker testing, importance of providing access to biomarker testing for underserved populations, how biomarkers are shaping the future of medicine, as well as what can be done at the policy level to allow for more access.

  • In the fifth webinar, we will hear from Angie Santiago, CRCS, Manager of Oncology Financial Advocacy, Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System, and Chair of ACCC’s Financial Advocacy Network, and Sarah Shaw, Oncology Program Manager at St. Luke’s Cancer Institute in Boise, ID. Join us as we discuss importance of medical necessity in oncology and how clear denial data can help maximize reimbursement.

  • In the fourth webinar, we will hear from Gretchen Van Dyck, Financial Counselor from St. Vincent Hospital Regional Cancer Center and Rachelle Gill, Program/Department Coordinator II for Proton Therapy Appeals at Fred Hutchinson Cancer Center. Join us as we discuss radiation authorization submissions before treatment and strategies on how to work radiation authorization denials and appeals after treatment.

 

Cancer Buzz Podcasts

From Oncology Issues

 

From the ACCCBuzz Blog

Celebrate Movember


November 21, 2019
Celebrate-November-240x160

Support for medical research into prostate treatments and cures has inspired a host of fundraising efforts during the past several decades. One charitable organization has inspired a movement that has transformed the month of November into “Movember” by encouraging men to grow facial hair. The charitable organization’s website proclaims, “In the month formerly known as November, Mo Bros and Mo Sisters across the world Grow a Mo [mustache].” Men are encouraged to grow creative mustaches to show their support for men’s health and to aid fundraising efforts for medical research.

In many ways, the fight against prostate cancer in the U.S. is an overwhelming success story. According to the American Cancer Society, prostate cancer death rates have declined 51 percent from 1993 to 2016 among U.S. men. Today, there are more than 3 million survivors of prostate cancer living in the U.S.

However, aside from non-melanoma skin cancer, prostate cancer remains the most common cancer among men in the U.S. Approximately one in nine men will be diagnosed with prostate cancer during his lifetime. In 2019, an estimated 174,650 men in this country will be diagnosed with the disease, and 31,620 men will die from it. What’s more, prostate cancer affects racial groups differently; African-American men are consistently diagnosed with prostate cancer at higher rates than white men, and black patients are twice as likely to die from prostate cancer as white patients.

Options for treating advanced prostate cancer are expanding with genetic research, which has revealed that the presence of mutations in key genes—including BRCA1 and BRCA2—can make the cancer particularly vulnerable to certain therapies. About one-third of prostate cancer patients have genetic mutations that can be targeted with existing drugs such as PARP.

This November, you can help further such research efforts by doing something relatively small. As Movember.com states, “The men’s health crisis calls for big minds and big solutions. But there’s a smaller, hairier solution to the men’s health crisis. A solution you can grow yourself. It’s sitting under your nose.”

Abstracts/Presentations